User:Oddvector/Seroconversion/Bibliography

Bibliography

Seroconversion sources thus far

Definition

Sources for the defintions of seroconversion,{{Cite web|title=Seroconversion {{!}} NIH|url=https://clinicalinfo.hiv.gov/en/glossary/seroconversion|access-date=2021-11-01|website=clinicalinfo.hiv.gov|language=en}} window period (which does not have a source for its definition),{{Cite web|title=Window Period {{!}} NIH|url=https://clinicalinfo.hiv.gov/en/glossary/window-period|access-date=2021-11-01|website=clinicalinfo.hiv.gov|language=en}} and false negative.{{Cite web|title=False Negative {{!}} NIH|url=https://clinicalinfo.hiv.gov/en/glossary/false-negative|access-date=2021-11-01|website=clinicalinfo.hiv.gov|language=en}}

Symptoms: This article currently lacks information about the symptoms of seroconversion for HIV and experience of the seroconversion period.

Overview of symptoms{{Cite web|title=Symptoms and seroconversion {{!}} Guides {{!}} HIV i-Base|url=https://i-base.info/guides/testing/symptoms-and-seroconversion|access-date=2021-11-01|website=i-base.info}}
More detailed information{{Citation|last=Hirschel|first=Bernard|title=93 - Primary HIV Infection|date=2017-01-01|url=https://www.sciencedirect.com/science/article/pii/B9780702062858000939|work=Infectious Diseases (Fourth Edition)|pages=846–849.e1|editor-last=Cohen|editor-first=Jonathan|publisher=Elsevier|language=en|doi=10.1016/b978-0-7020-6285-8.00093-9|isbn=978-0-7020-6285-8|access-date=2021-11-01|editor2-last=Powderly|editor2-first=William G.|editor3-last=Opal|editor3-first=Steven M.}}

Additional information: seroconversion has farther reaching implications than those listed in this article

Seroconversion's clinically relevant usage in detecting Kaposi sarcoma early for HIV patients{{Cite journal|last=Renwick|first=N.|last2=Halaby|first2=T.|last3=Weverling|first3=G. J.|last4=Dukers|first4=N. H.|last5=Simpson|first5=G. R.|last6=Coutinho|first6=R. A.|last7=Lange|first7=J. M.|last8=Schulz|first8=T. F.|last9=Goudsmit|first9=J.|date=1998-12-24|title=Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma|url=https://pubmed.ncbi.nlm.nih.gov/9875587/|journal=AIDS (London, England)|volume=12|issue=18|pages=2481–2488|doi=10.1097/00002030-199818000-00018|issn=0269-9370|pmid=9875587}}
Seroconversion with respect to maternal antibodies and its impact on vaccination{{Cite journal|last=Siegrist|first=C|date=2003-07-28|title=Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants|url=https://linkinghub.elsevier.com/retrieve/pii/S0264410X03003426|journal=Vaccine|language=en|volume=21|issue=24|pages=3406–3412|doi=10.1016/S0264-410X(03)00342-6}}

Mechanism of seroconversion: the mechanism section on the page currently has zero sources.

Information about seroconversion in COVID-19{{Cite web|title=COVID-19 Serology Testing Explained|url=https://asm.org/Articles/2020/May/COVID-19-Serology-Testing-Explained|access-date=2021-11-01|website=ASM.org|language=en}}
Basic explanation of seroconversion mechanism{{Cite web|title=The Immune Response against Pathogens {{!}} Anatomy and Physiology|url=https://courses.lumenlearning.com/nemcc-ap/chapter/the-immune-response-against-pathogens/|access-date=2021-11-01|website=courses.lumenlearning.com}}
Mechanism of antibody-antigen binding{{Cite journal|last=van Oss|first=C. J.|last2=Good|first2=R. J.|last3=Chaudhury|first3=M. K.|date=1986-04-11|title=Nature of the antigen-antibody interaction. Primary and secondary bonds: optimal conditions for association and dissociation|url=https://pubmed.ncbi.nlm.nih.gov/3711190/|journal=Journal of Chromatography|volume=376|pages=111–119|pmid=3711190}}

COVID-19 specific information: more COVID-19 specific information has arisen since the article was last updated, which may be of relevant information to persons checking the page for understanding of the pandemic.

Asymptomatic seroconversion,{{Cite journal|last=Hains|first=David S.|last2=Schwaderer|first2=Andrew L.|last3=Carroll|first3=Aaron E.|last4=Starr|first4=Michelle C.|last5=Wilson|first5=Amy C.|last6=Amanat|first6=Fatima|last7=Krammer|first7=Florian|date=2020-06-16|title=Asymptomatic Seroconversion of Immunoglobulins to SARS-CoV-2 in a Pediatric Dialysis Unit|url=https://jamanetwork.com/journals/jama/fullarticle/2766215|journal=JAMA|language=en|volume=323|issue=23|pages=2424|doi=10.1001/jama.2020.8438|issn=0098-7484|pmc=PMC7226282|pmid=32407440}} to better differentiate from HIV-related seroconversion
Differentiation of pathophysiology of COVID-19 based on seroconversion,{{Cite journal|last=Galbraith|first=Matthew D|last2=Kinning|first2=Kohl T|last3=Sullivan|first3=Kelly D|last4=Baxter|first4=Ryan|last5=Araya|first5=Paula|last6=Jordan|first6=Kimberly R|last7=Russell|first7=Seth|last8=Smith|first8=Keith P|last9=Granrath|first9=Ross E|last10=Shaw|first10=Jessica R|last11=Dzieciatkowska|first11=Monika|date=2021-03-16|editor-last=Schoggins|editor-first=John W|editor2-last=Sawyer|editor2-first=Sara L|editor3-last=Khor|editor3-first=Bernard|title=Seroconversion stages COVID19 into distinct pathophysiological states|url=https://doi.org/10.7554/eLife.65508|journal=eLife|volume=10|pages=e65508|doi=10.7554/eLife.65508|issn=2050-084X}} with possible differences in therapy
Seroconversion from the COVID-19 vaccine{{Cite journal|last=Sahin|first=Ugur|last2=Muik|first2=Alexander|last3=Derhovanessian|first3=Evelyna|last4=Vogler|first4=Isabel|last5=Kranz|first5=Lena M.|last6=Vormehr|first6=Mathias|last7=Baum|first7=Alina|last8=Pascal|first8=Kristen|last9=Quandt|first9=Jasmin|last10=Maurus|first10=Daniel|last11=Brachtendorf|first11=Sebastian|date=2021-01-19|title=COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses|url=https://www.nature.com/articles/s41586-020-2814-7|journal=Nature|language=en|volume=586|issue=7830|pages=594–599|doi=10.1038/s41586-020-2814-7|issn=1476-4687}}
Differences in seroconversion in different populations{{Cite journal|last=Soytas|first=Rabia Bag|last2=Cengiz|first2=Mahir|last3=Islamoglu|first3=Mehmet Sami|last4=Uysal|first4=Betul Borku|last5=Ikitimur|first5=Hande|last6=Yavuzer|first6=Hakan|last7=Yavuzer|first7=Serap|date=2021|title=Does the COVID-19 seroconversion in older adults resemble the young?|url=https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27106|journal=Journal of Medical Virology|language=en|volume=93|issue=10|pages=5777–5782|doi=10.1002/jmv.27106|issn=1096-9071|pmc=PMC8242906|pmid=34042191}}
Factors leading to nonseroconversion{{Cite journal|last=Liu|first=Weimin|last2=Russell|first2=Ronnie M.|last3=Bibollet-Ruche|first3=Frederic|last4=Skelly|first4=Ashwin N.|last5=Sherrill-Mix|first5=Scott|last6=Freeman|first6=Drew A.|last7=Stoltz|first7=Regina|last8=Lindemuth|first8=Emily|last9=Lee|first9=Fang-Hua|last10=Sterrett|first10=Sarah|last11=Bar|first11=Katharine J.|title=Predictors of Nonseroconversion after SARS-CoV-2 Infection - Volume 27, Number 9—September 2021 - Emerging Infectious Diseases journal - CDC|url=https://wwwnc.cdc.gov/eid/article/27/9/21-1042_article|language=en-us|doi=10.3201/eid2709.211042}}